{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:49:41Z","timestamp":1759009781020},"reference-count":28,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.vaccine.2011.01.103","type":"journal-article","created":{"date-parts":[[2011,2,15]],"date-time":"2011-02-15T15:14:12Z","timestamp":1297782852000},"page":"2785-2790","source":"Crossref","is-referenced-by-count":13,"title":["Sub-optimal prevalence of mumps antibodies in a population based study of young adults in Israel after 20 years of two dose universal vaccination policy"],"prefix":"10.1016","volume":"29","author":[{"given":"Hagai","family":"Levine","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omer E.","family":"Ankol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladi","family":"Rozhavski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadav","family":"Davidovitch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yair","family":"Aboudy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salman","family":"Zarka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ran D.","family":"Balicer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2011.01.103_bib0005","series-title":"Control of communicable diseases, manual","article-title":"Mumps","author":"Heymann","year":"2008"},{"key":"10.1016\/j.vaccine.2011.01.103_bib0010","series-title":"Vaccines","first-page":"435","article-title":"Mumps vaccine","author":"Plotkin","year":"2008"},{"key":"10.1016\/j.vaccine.2011.01.103_bib0015","first-page":"R21","article-title":"Mumps surveillance in England and Wales supports introduction of two dose vaccination schedule","volume":"7","author":"Gay","year":"1997","journal-title":"Commun Dis Rep CDR Rev"},{"key":"10.1016\/j.vaccine.2011.01.103_bib0020","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1056\/NEJMoa0706589","article-title":"Recent resurgence of mumps in the United States","volume":"358","author":"Dayan","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2011.01.103_bib0025","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S1473-3099(08)70282-2","article-title":"Measles, mumps and rubella in Finland: 25 years of a nationwide elimination programme","volume":"8","author":"Peltola","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2011.01.103_bib0030","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0140-6736(09)61757-8","article-title":"Prevention is better than cure","volume":"375","author":"Borysiewicz","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2011.01.103_bib0035","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0140-6736(10)60175-4","article-title":"Retraction: ileal lymphoid nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children","volume":"375","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2011.01.103_bib0040","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.vaccine.2005.07.063","article-title":"A survey of UK parental attitudes to the MMR vaccine and trust in medical authority","volume":"24","author":"Casiday","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.01.103_bib0045","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1017\/S0950268807008989","article-title":"Prevalence of mumps antibodies in the Israeli population in relation to mumps vaccination policy and incidence of disease","volume":"136","author":"Muhsen","year":"2008","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2011.01.103_bib0050","series-title":"Notifiable Infectious Diseases in Israel: 1951\u20132004","author":"Israel Center for Disease Control","year":"2006"},{"key":"10.1016\/j.vaccine.2011.01.103_bib0055","first-page":"125","article-title":"Update: mumps outbreak \u2013 New York and New Jersey, June 2009\u2013January 2010","volume":"59","author":"Centers for Disease Control (CDC)","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"50","key":"10.1016\/j.vaccine.2011.01.103_bib0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2807\/ese.14.50.19440-en","article-title":"Mumps outbreak in Jerusalem affecting mainly male adolescents","volume":"14","author":"Stein-Zamir","year":"2009","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2011.01.103_bib0065","first-page":"733","article-title":"Prevalence of antibodies against measles, mumps and rubella in Israeli young adults","volume":"28","author":"Danon","year":"1992","journal-title":"Isr J Med Sci"},{"key":"10.1016\/j.vaccine.2011.01.103_bib0070","doi-asserted-by":"crossref","first-page":"6300","DOI":"10.1016\/j.vaccine.2006.05.072","article-title":"Declining population immunity to mumps among Israeli military recruits","volume":"24","author":"Huerta","year":"2006","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2011.01.103_bib0075","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1503\/cmaj.060660","article-title":"Two successive outbreaks of mumps in Nova Scotia among vaccinated adolescents and young adults","volume":"175","author":"Watson-Creed","year":"2006","journal-title":"CMAJ"},{"key":"10.1016\/j.vaccine.2011.01.103_bib0080","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/0140-6736(90)90420-A","article-title":"Immunization and herd immunity","volume":"335","author":"Anderson","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2011.01.103_bib0085","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1086\/655395","article-title":"Mumps control today","volume":"202","author":"Quinlisk","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.01.103_bib0090","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1086\/528993","article-title":"Persistence of measles, mumps and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow up","volume":"197","author":"Davidkin","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.01.103_bib0095","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1086\/588197","article-title":"Long term persistence of mumps antibody after receipt of 2 MMR vaccinations and antibody response after a third MMR vaccination among a university population","volume":"197","author":"Date","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.01.103_bib0100","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1086\/520028","article-title":"Mumps outbreaks in Canada and the United States: time for new thinking on mumps vaccines","volume":"45","author":"Peltola","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2011.01.103_bib0105","series-title":"Vaccines","first-page":"1582","article-title":"Community immunity","author":"Fine","year":"2008"},{"key":"10.1016\/j.vaccine.2011.01.103_bib0110","doi-asserted-by":"crossref","first-page":"6186","DOI":"10.1016\/j.vaccine.2009.06.109","article-title":"Mumps resurgences in the United States: a historical perspective on unexpected elements","volume":"27","author":"Barskey","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.01.103_bib0115","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0264-410X(01)00435-2","article-title":"Immunogenicity of second dose measles\u2013mumps\u2013rubella (MMR) vaccine and implications for serosurveillance","volume":"20","author":"Pebody","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.01.103_bib0120","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/S0264-410X(00)00392-3","article-title":"Mumps virus neutralizing antibodies do not protect against reinfection whith a heterologous mumps virus genotype","volume":"19","author":"Nojd","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.01.103_bib0125","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1086\/590115","article-title":"Antibody induced by immunization with the Jeryl Lynn mumps vaccine strain effectively neutralizes heterologous wild type mumps virus associated with a large outbreak","volume":"198","author":"Rubin","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.01.103_bib0130","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.1016\/j.vaccine.2010.06.031","article-title":"Control of Streptococcus pneumoniae serotype 5 epidemic of severe pneumonia among young army recruits by mass antibiotic treatment and vaccination","volume":"28","author":"Balicer","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.01.103_bib0135","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.vaccine.2007.11.035","article-title":"Incidence of mumps and immunity to measles, mumps and rubella among US military recruits, 2000\u20132004","volume":"26","author":"Eick","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.01.103_bib0140","doi-asserted-by":"crossref","first-page":"7228","DOI":"10.1016\/j.vaccine.2010.08.055","article-title":"Antibody persistence in young adults 1 year after MMR immunization by aerosol or by subcutaneous route","volume":"28","author":"Diaz-Ortega","year":"2010","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11001757?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11001757?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T00:29:37Z","timestamp":1637281777000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11001757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":28,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0264410X11001757"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.01.103","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}